Genome-wide association studies have suggested that individuals with variants of immune genes such as CD33 and TREM2 are at greater risk of developing AD, and single-cell RNA sequencing studies suggest that immunologically activated microglia are present in both animal models of AD and tissue from AD patients [61–65]. The gene discussed is TREM2; the disease is Alzheimer disease.